SCHEMBL20140390

SCHEMBL20140390

COC(=O)C1(c2ccc(F)cc2)CN(C(=O)OC(C)(C)C)CC1c1ccc(Br)cc1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RORC P51449 15/20 0.57
OPRK1 P41145 1/20 0.41
USP30 Q70CQ3 1/20 0.40
ROCK2 O75116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20142353 1.00 RORC (0.57) RORCOPRK1USP30ROCK2
SCHEMBL20139749 0.90 RORC (0.62) RORCUSP30
SCHEMBL20139748 0.90 RORC (0.62) RORCUSP30
SCHEMBL20140441 0.84 RORC (0.80) RORC
SCHEMBL20139603 0.84 RORC (0.80) RORC
SCHEMBL23683608 0.81 RORC (0.58) RORCUSP30
SCHEMBL20139710 0.81 RORC (0.58) RORCUSP30
SCHEMBL20139636 0.75 RORC (0.58) RORC
SCHEMBL23683600 0.75 RORC (0.58) RORC
SCHEMBL20139612 0.75 RORC (0.46) RORCUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078186-B2 ROR γ modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2021-08-03 US disclosed
EP-3538522-A1 ROR GAMMA MODULATORS Bristol-Myers Squibb Company (US) 2019-09-18 EP disclosed
WO-2018089406-A1 ROR GAMMA MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078186-B2 ROR γ modulators RORB, RORC, RORA RORC 2/4885OPRK1 308/4885USP30 3278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.